Personalized management of lung cancer

2013 ◽  
pp. 2-5
Author(s):  
Ritsuko Komaki
Keyword(s):  
Lung Cancer ◽  
Personalized Management

Personalized management for non-small-cell lung cancer

2011 ◽  
pp. 58-67
Author(s):  
Martin Früh ◽  
Florent Baty ◽  
Lukas Kern ◽  
Martin P Putora ◽  
Martin Brutsche
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Personalized Management

The Current and Evolving Role of PET in Personalized Management of Lung Cancer

PET Clinics ◽  
2016 ◽  
Vol 11 (3) ◽  
pp. 243-259 ◽  
Author(s):  
Esther Mena ◽  
Anusha Yanamadala ◽  
Gang Cheng ◽  
Rathan M. Subramaniam
Keyword(s):  
Lung Cancer ◽  
Personalized Management

The landscape ofEGFRpathways and personalized management of non-small-cell lung cancer

2011 ◽  
Vol 7 (4) ◽  
pp. 519-541 ◽  
Author(s):  
Liang Cheng ◽  
Shaobo Zhang ◽  
Riley Alexander ◽  
Yongxue Yao ◽  
Gregory T MacLennan ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Personalized Management

Comment: predictability of survival in the individual patient with lung cancer

JAMA ◽  
1966 ◽  
Vol 195 (12) ◽  
pp. 1036-1037 ◽  
Author(s):  
P. Rubin
Keyword(s):  
Lung Cancer ◽  
The Individual

The question of irradiation therapy in lung cancer

JAMA ◽  
1966 ◽  
Vol 195 (6) ◽  
pp. 471-475 ◽  
Author(s):  
M. J. Krant
Keyword(s):  
Lung Cancer ◽  
Irradiation Therapy

Surgery for Lung Cancer and the Consequences for the Swallow

2016 ◽  
Vol 1 (13) ◽  
pp. 162-168
Author(s):  
Pippa Hales ◽  
Corinne Mossey-Gaston
Keyword(s):  
Lung Cancer ◽  
Treatment Options ◽  
Vocal Cord Palsy ◽  
Subsequent Treatment ◽  
Physiological Reserve ◽  
Palliative Phase ◽  
And Function ◽  
The Impact ◽  
Swallow Function

Lung cancer is one of the most commonly diagnosed cancers across Northern America and Europe. Treatment options offered are dependent on the type of cancer, the location of the tumor, the staging, and the overall health of the person. When surgery for lung cancer is offered, difficulty swallowing is a potential complication that can have several influencing factors. Surgical interaction with the recurrent laryngeal nerve (RLN) can lead to unilateral vocal cord palsy, altering swallow function and safety. Understanding whether the RLN has been preserved, damaged, or sacrificed is integral to understanding the effect on the swallow and the subsequent treatment options available. There is also the risk of post-surgical reduction of physiological reserve, which can reduce the strength and function of the swallow in addition to any surgery specific complications. As lung cancer has a limited prognosis, the clinician must also factor in the palliative phase, as this can further increase the burden of an already compromised swallow. By understanding the surgery and the implications this may have for the swallow, there is the potential to reduce the impact of post-surgical complications and so improve quality of life (QOL) for people with lung cancer.

Use of Tumor Markers in Lung Cancer

1994 ◽  
Vol 8 (3) ◽  
pp. 507-532 ◽  
Author(s):  
Gary M. Strauss ◽  
Arthur T. Skarin
Keyword(s):  
Lung Cancer ◽  
Tumor Markers
Sign in / Sign up

Export Citation Format

Share Document